Potential of drug interactions among hospitalized cancer patients in a developing country

ABSTRACT

Cancer patients are more susceptible to adverse drug-drug interactions [DDIs] due to receiving multiple medications especially chemotherapy medications, hormonal agents and supportive care drugs. The aim of this study is to describe the prevalence of potential DDIs and to identify risk factors for these potential interactions in hospitalized cancer patients in a developing country